Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -15.990\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. C=CCn1c(SCC(=O)N2CCOCC2)nc2sc3c(c2c1=O)CCCC3
b. N#CCCN(C(=O)CSc1ccc2c(c1)OCCO2)c1ccccc1
Answer: a. C=CCn1c(SCC(=O)N2CCOCC2)nc2sc3c(c2c1=O)CCCC3
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C=CCn1c(SCC(=O)N2CCOCC2)nc2sc3c(c2c1=O)CCCC3
C=CCn1c(SCC(=O)N2CCOCC2)nc2sc3c(c2c1=O)CCCC3
2-(2-morpholin-4-yl-2-oxoethyl)sulfanyl-3-prop-2-enyl-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-4-one